169 related articles for article (PubMed ID: 32055929)
1. Plasmablastic IgM multiple myeloma with hypocellular bone marrow.
Arter ZL; Miles D; Mignano S; Cordaro D; Roswarski J
Ann Hematol; 2020 Apr; 99(4):895-896. PubMed ID: 32055929
[No Abstract] [Full Text] [Related]
2. Defining IgM multiple myeloma.
Owen RG; Feyler S; O'Connor SJ; Bond LR; de Tute RM; Rawstron AC
Am J Hematol; 2011 Aug; 86(8):717; author reply 718-9. PubMed ID: 21761439
[No Abstract] [Full Text] [Related]
3. IgM multiple myeloma: more on a rare and heterogeneous disease.
Cabrera Q; Chantepie S; Salaun V; Levaltier X; Troussard X; Macro M
Am J Hematol; 2011 Aug; 86(8):717-8; author reply 718-9. PubMed ID: 21630314
[No Abstract] [Full Text] [Related]
4. Bone marrow infiltration by plasmablastic neoplasm: plasmablastic myeloma or plasmablastic lymphoma?
Eladl E; Chang H
Blood; 2021 Mar; 137(9):1268. PubMed ID: 33661296
[No Abstract] [Full Text] [Related]
5. Plasmablastic multiple myeloma with Dutcher bodies.
Jain D; Singh T
Indian J Pathol Microbiol; 2008; 51(3):442-3. PubMed ID: 18723987
[No Abstract] [Full Text] [Related]
6. IgM myeloma: A multicenter retrospective study of 134 patients.
Castillo JJ; Jurczyszyn A; Brozova L; Crusoe E; Czepiel J; Davila J; Dispenzieri A; Eveillard M; Fiala MA; Ghobrial IM; Gozzetti A; Gustine JN; Hajek R; Hungria V; Jarkovsky J; Jayabalan D; Laubach JP; Lewicka B; Maisnar V; Manasanch EE; Moreau P; Morgan EA; Nahi H; Niesvizky R; Paba-Prada C; Pika T; Pour L; Reagan JL; Richardson PG; Shah J; Spicka I; Vij R; Waszczuk-Gajda A; Gertz MA
Am J Hematol; 2017 Aug; 92(8):746-751. PubMed ID: 28383205
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow trephine biopsy findings in myeloma with small-lymphoid cells and CCND1 translocation.
Abdalla S; May PC; Garimberti E; Naresh KN
Am J Hematol; 2011 Dec; 86(12):1038. PubMed ID: 21898528
[No Abstract] [Full Text] [Related]
8. Foamy Plasma Cells in Oligosecretory Multiple Myeloma.
Ferrara G; Broglia I; Mariani MP
Int J Surg Pathol; 2021 Jun; 29(4):408-409. PubMed ID: 32419548
[No Abstract] [Full Text] [Related]
9. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
[TBL] [Abstract][Full Text] [Related]
10. Circulating plasma cells with Russell bodies in osteosclerotic myeloma.
Chen M; Green R
Blood; 2013 Jul; 122(2):160. PubMed ID: 24006527
[No Abstract] [Full Text] [Related]
11. IgM k multiple myeloma with monoclonal surface immunoglobulin expression.
Laribi K; Alani M; Lemaire P
Int J Hematol; 2018 Jul; 108(1):3-4. PubMed ID: 29779080
[No Abstract] [Full Text] [Related]
12. Spindle cell lesion in the bone marrow.
Guzman S; Kitahara S
Blood; 2018 Sep; 132(10):1085. PubMed ID: 30190353
[No Abstract] [Full Text] [Related]
13. Diagnosis and risk stratification in multiple myeloma.
van de Donk NW; Sonneveld P
Hematol Oncol Clin North Am; 2014 Oct; 28(5):791-813. PubMed ID: 25212883
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin M concentration in Waldenström macroglobulinemia: correlation with bone marrow B cells and plasma cells.
de Tute RM; Rawstron AC; Owen RG
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):211-3. PubMed ID: 23523273
[TBL] [Abstract][Full Text] [Related]
15. Morphologic heterogeneity and plasmablastic transformation in advanced plasmacytic/plasmablastic myeloma: a study of 35 serial bone marrow biopsies in 9 patients.
Paule B; Quillard J; Bennet P; Mariette X; Bisson M
Nouv Rev Fr Hematol (1978); 1989; 31(3):203-8. PubMed ID: 2616267
[TBL] [Abstract][Full Text] [Related]
16. The identity of light chains of monoclonal IgG and monoclonal IgM in one patient.
Wang AC; Wang IY; McCormick JN; Fudenberg HH
Immunochemistry; 1969 May; 6(3):451-9. PubMed ID: 4182364
[No Abstract] [Full Text] [Related]
17. Discrepancies between the percentage of plasma cells in bone marrow aspiration and BM biopsy: Impact on the revised IMWG diagnostic criteria of multiple myeloma.
Lee N; Moon SY; Lee JH; Park HK; Kong SY; Bang SM; Lee JH; Yoon SS; Lee DS
Blood Cancer J; 2017 Feb; 7(2):e530. PubMed ID: 28211888
[No Abstract] [Full Text] [Related]
18. Toward development of a novel NOD/SCID-based in vivo strategy to model multiple myeloma pathogenesis.
Bueno C; Lopes LF; Greaves M; Menendez P
Exp Hematol; 2007 Oct; 35(10):1477-8. PubMed ID: 17681665
[No Abstract] [Full Text] [Related]
19. Intravoxel incoherent motion imaging for assessment of bone marrow infiltration of monoclonal plasma cell diseases.
Shah R; Stieltjes B; Andrulis M; Pfeiffer R; Sumkauskaite M; Delorme S; Schlemmer HP; Goldschmidt H; Landgren O; Hillengass J
Ann Hematol; 2013 Nov; 92(11):1553-7. PubMed ID: 23680869
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of plasma cell morphology in multiple myeloma.
Paule B; Quillard J; Bisson M; Kahn MF; Massias P
Nouv Rev Fr Hematol (1978); 1988; 30(4):209-12. PubMed ID: 3194186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
